SEC 13F Intelligence

Marathon Capital Management / AZNN

Marathon Capital Management’s Astrazeneca PLC Position

Does Marathon Capital Management own Astrazeneca PLC (AZNN)? Not currently — the last reported position was 157.7K shares worth $15M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$15M
Q4 2025
Shares
157.7K
% of Portfolio
+3.12%
Quarters Held
9
position exited

Position History AZNN

Reported value by quarter
Q4 ’23: $6MQ4 ’23Q1 ’24: $11MQ2 ’24: $13MQ2 ’24Q3 ’24: $13MQ4 ’24: $11MQ4 ’24Q1 ’25: $12MQ2 ’25: $11MQ2 ’25Q3 ’25: $12MQ4 ’25: $15MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2025157.7K$15M+3.12%
Q3 2025161.0K$12M+2.83%
Q2 2025163.4K$11M+2.91%
Q1 2025166.3K$12M+3.26%
Q4 2024168.1K$11M+2.75%
Q3 2024163.0K$13M+3.08%
Q2 2024161.9K$13M+3.22%
Q1 2024162.1K$11M+2.62%
Q4 202395.2K$6M+1.61%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Marathon Capital Management’s full portfolio or all institutional holders of AZNN.